Therapeutic efficacy of atorvastatin in chronic idiopathic utricaria
Phase 2
- Conditions
- Idiopathic urticaria.Idiopathic urticaria
- Registration Number
- IRCT201110033862N8
- Lead Sponsor
- Research Council of Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 66
Inclusion Criteria
presence of utricaria more than 8 weeks, Normality of thyroids assay test, Negativity of antithyroglobulin, antimicrosomal antibodies and skin prick test for inhale and oral common allergens
Exclusion criteria: Addiction, Systemic and chronic diseases, Pregnancy
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method tricaria severity. Timepoint: Baseline and at the end of treatment course. Method of measurement: Utricaria severity is calculated according to Breneman et al to 4 categories; Mild, Moderate and sever.
- Secondary Outcome Measures
Name Time Method Cytokines Variations. Timepoint: baseline and after the treatment course. Method of measurement: Measuring selective cytokines by Eliza method in lymphocyte culture.